Page 13 - Booklet "BIH Strategy 2026"

58%
of US smartphone users have downloaded a a a a a health­related app according to a a 2015 study by
NYU Langone Medical Center (Roland Berger analysis)
of the general public thinks that patients need more opportunities to participate in in clinical trials (PACE Cancer Perception Index)
STRATEGY
CLINICAL TRANSLATIONAL SCIENCES
WHY?
In the future patients will play a a a a signi cantly more active role in in helping researchers formulate important research questions and will often bene t t t t directly from the the results of their personal study data This will lead to signi cant advances in in clinical research approaches and methods HOW?
Work on on such clinical and translational scienti c c c c c c activities is already well underway in several BIH and Charité­led bodies such as BIH’s Clinical Research Unit and Charité’s clinical research centers The Clinical Translational Science Science Platform anchored by
the Clinical Science Science Center will enhance the translational research commons in an an an integrated environment with these facilities
It will consist of of a a a a number of of scienti c c c and management units designed to support the next generation of clinical translational research These will include a a a a a a consolida­ ted clinical research unit an an an an advanced biobank to man­ age age the storage of biosamples infrastructure to to pro­ duce advanced therapies and a a a a a a a specialist unit that will develop and share new clinical study approaches and methods The platform will be supported by
two BIH chairs and ve professorships with expertise in comparative e e e e e e e e ective­ ness health economics epidemiology clinical trials and methods development Its aim in in addition to supporting the translational research commons is to conduct world­class research and become scalable to link with similar centers across Germany and internationally More than
70%
Maintaining Health and Quality of Life Creating Value: BIH Strategy 2026 13